Skip to main content
Erschienen in: Current Pain and Headache Reports 11/2023

23.08.2023 | Chronic Daily Headache (S-J Wang and S-P Chen, Section Editors)

Non-Pharmacological Treatment for Chronic Migraine

verfasst von: Xun Han, Shengyuan Yu

Erschienen in: Current Pain and Headache Reports | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Chronic migraine (CM) affects a large proportion of the population and is a significant source of disability and lost productivity. Numerous non-pharmacological approaches have been attempted during the past decades. This review discusses the most recent and evidence-based advances in acute and preventive non-pharmacological therapeutic approaches for CM, offering alternatives to drug treatment.

Recent Findings

A growing number of non-pharmacological treatment options, including non-invasive or invasive neuromodulation, acupuncture, psychotherapy, and physiotherapy, have shown promising efficacy in CM. There is strong evidence for the effectiveness of non-invasive neuromodulation such as transcranial magnetic stimulation, transcranial direct current stimulation, and transcutaneous electrical nerve stimulation (TENS) in CM, but less evidence for approaches such as invasive neuromodulation, physical therapy, or dietary approaches. Acupuncture for migraine remains controversial, with the main point of contention still being the placebo effect.

Summary

Non-pharmacological approaches can be offered as a reliable alternative for patients with CM, and more research is being done to evaluate the efficacy of non-invasive neuromodulation with different parameters and the combination of different treatments in CM.
Literatur
2.
Zurück zum Zitat Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010;30(5):599–609.PubMedCrossRef Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010;30(5):599–609.PubMedCrossRef
3.
Zurück zum Zitat Thorlund K, Toor K, Wu P, Chan K, Druyts E, Ramos E, et al. Comparative tolerability of treatments for acute migraine: a network meta-analysis. Cephalalgia. 2017;37(10):965–78.PubMedCrossRef Thorlund K, Toor K, Wu P, Chan K, Druyts E, Ramos E, et al. Comparative tolerability of treatments for acute migraine: a network meta-analysis. Cephalalgia. 2017;37(10):965–78.PubMedCrossRef
4.
Zurück zum Zitat Hepp Z, Dodick DW, Varon SF, Chia J, Matthew N, Gillard P, et al. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis. Cephalalgia. 2017;37(5):470–85.PubMedCrossRef Hepp Z, Dodick DW, Varon SF, Chia J, Matthew N, Gillard P, et al. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis. Cephalalgia. 2017;37(5):470–85.PubMedCrossRef
5.
Zurück zum Zitat Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia. 2015;35(6):478–88.PubMedCrossRef Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia. 2015;35(6):478–88.PubMedCrossRef
6.
Zurück zum Zitat Turner DP, Golding AN, Houle TT. Using a graphical risk tool to examine willingness to take migraine prophylactic medications. Pain. 2016;157(10):2226–34.PubMedPubMedCentralCrossRef Turner DP, Golding AN, Houle TT. Using a graphical risk tool to examine willingness to take migraine prophylactic medications. Pain. 2016;157(10):2226–34.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Mouaanaki S, Carlsen L, Bendtsen L, Jensen R, Schytz H. Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center. Cephalalgia. 2022;42:1265–73.PubMedCrossRef Mouaanaki S, Carlsen L, Bendtsen L, Jensen R, Schytz H. Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center. Cephalalgia. 2022;42:1265–73.PubMedCrossRef
8.
Zurück zum Zitat Reuter U, McClure C, Liebler E, Pozo-Rosich P. Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials. J Neurol Neurosurg Psychiatry. 2019;90(7):796–804.PubMedCrossRef Reuter U, McClure C, Liebler E, Pozo-Rosich P. Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials. J Neurol Neurosurg Psychiatry. 2019;90(7):796–804.PubMedCrossRef
9.
Zurück zum Zitat Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain. 2016;139(Pt 7):2002–14.PubMedPubMedCentralCrossRef Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain. 2016;139(Pt 7):2002–14.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Bhola R, Kinsella E, Giffin N, Lipscombe S, Ahmed F, Weatherall M, et al. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain. 2015;16:535.PubMedCrossRef Bhola R, Kinsella E, Giffin N, Lipscombe S, Ahmed F, Weatherall M, et al. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain. 2015;16:535.PubMedCrossRef
11.
Zurück zum Zitat Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, et al. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). Cephalalgia. 2018;38(6):1038–48.PubMedPubMedCentralCrossRef Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, et al. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). Cephalalgia. 2018;38(6):1038–48.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Kalita J, Bhoi SK, Misra UK. Effect of high rate rTMS on somatosensory evoked potential in migraine. Cephalalgia. 2017;37(13):1222–30.PubMedCrossRef Kalita J, Bhoi SK, Misra UK. Effect of high rate rTMS on somatosensory evoked potential in migraine. Cephalalgia. 2017;37(13):1222–30.PubMedCrossRef
13.
Zurück zum Zitat Zhong J, Lan W, Feng Y, Yu L, Xiao R, Shen Y, et al. Efficacy of repetitive transcranial magnetic stimulation on chronic migraine: a meta-analysis. Front Neurol. 2022;13:1050090.PubMedPubMedCentralCrossRef Zhong J, Lan W, Feng Y, Yu L, Xiao R, Shen Y, et al. Efficacy of repetitive transcranial magnetic stimulation on chronic migraine: a meta-analysis. Front Neurol. 2022;13:1050090.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Teo WP, Kannan A, Loh PK, Chew E, Sharma VK, Chan YC. Poor tolerance of motor cortex rTMS in chronic migraine. J Clin Diagn Res. 2014;8(9):MM01–2. Teo WP, Kannan A, Loh PK, Chew E, Sharma VK, Chan YC. Poor tolerance of motor cortex rTMS in chronic migraine. J Clin Diagn Res. 2014;8(9):MM01–2.
15.
Zurück zum Zitat Kalita J, Laskar S, Bhoi SK, Misra UK. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache. J Neurol. 2016;263(11):2238–46.PubMedCrossRef Kalita J, Laskar S, Bhoi SK, Misra UK. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache. J Neurol. 2016;263(11):2238–46.PubMedCrossRef
16.
Zurück zum Zitat Kumar A, Mattoo B, Bhatia R, Kumaran S, Bhatia R. Neuronavigation based 10 sessions of repetitive transcranial magnetic stimulation therapy in chronic migraine: an exploratory study. Neurol Sci. 2021;42(1):131–9.PubMedCrossRef Kumar A, Mattoo B, Bhatia R, Kumaran S, Bhatia R. Neuronavigation based 10 sessions of repetitive transcranial magnetic stimulation therapy in chronic migraine: an exploratory study. Neurol Sci. 2021;42(1):131–9.PubMedCrossRef
17.
Zurück zum Zitat Shehata HS, Esmail EH, Abdelalim A, El-Jaafary S, Elmazny A, Sabbah A, et al. Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial. J Pain Res. 2016;9:771–7.PubMedPubMedCentralCrossRef Shehata HS, Esmail EH, Abdelalim A, El-Jaafary S, Elmazny A, Sabbah A, et al. Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial. J Pain Res. 2016;9:771–7.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat •• Kalita J, Kumar S, Singh VK, Misra UK. A randomized controlled trial of high rate rTMS versus rTMS and amitriptyline in chronic migraine. Pain Physician. 2021;24(6):E733–41. Combination of rTMS and amitriptyline in CM. •• Kalita J, Kumar S, Singh VK, Misra UK. A randomized controlled trial of high rate rTMS versus rTMS and amitriptyline in chronic migraine. Pain Physician. 2021;24(6):E733–41. Combination of rTMS and amitriptyline in CM.
19.
Zurück zum Zitat Rapinesi C, Del Casale A, Scatena P, Kotzalidis GD, Di Pietro S, Ferri VR, et al. Add-on deep transcranial magnetic stimulation (dTMS) for the treatment of chronic migraine: a preliminary study. Neurosci Lett. 2016;623:7–12.PubMedCrossRef Rapinesi C, Del Casale A, Scatena P, Kotzalidis GD, Di Pietro S, Ferri VR, et al. Add-on deep transcranial magnetic stimulation (dTMS) for the treatment of chronic migraine: a preliminary study. Neurosci Lett. 2016;623:7–12.PubMedCrossRef
20.
Zurück zum Zitat Andrade SM, de Brito Aranha REL, de Oliveira EA, de Mendonca C, Martins WKN, Alves NT, et al. Transcranial direct current stimulation over the primary motor vs prefrontal cortex in refractory chronic migraine: a pilot randomized controlled trial. J Neurol Sci. 2017;378:225–32.PubMedCrossRef Andrade SM, de Brito Aranha REL, de Oliveira EA, de Mendonca C, Martins WKN, Alves NT, et al. Transcranial direct current stimulation over the primary motor vs prefrontal cortex in refractory chronic migraine: a pilot randomized controlled trial. J Neurol Sci. 2017;378:225–32.PubMedCrossRef
21.
Zurück zum Zitat Cortese F, Pierelli F, Bove I, Di Lorenzo C, Evangelista M, Perrotta A, et al. Anodal transcranial direct current stimulation over the left temporal pole restores normal visual evoked potential habituation in interictal migraineurs. J Headache Pain. 2017;18(1):70.PubMedPubMedCentralCrossRef Cortese F, Pierelli F, Bove I, Di Lorenzo C, Evangelista M, Perrotta A, et al. Anodal transcranial direct current stimulation over the left temporal pole restores normal visual evoked potential habituation in interictal migraineurs. J Headache Pain. 2017;18(1):70.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat • Aksu S, Şirin TC, Hasırcı Bayır BR, Ulukan Ç, Soyata AZ, Kurt A, et al. Long-term prophylactic transcranial direct current stimulation ameliorates allodynia and improves clinical outcomes in individuals with migraine. Neuromodulation. 2022. Long-term tDCS study. • Aksu S, Şirin TC, Hasırcı Bayır BR, Ulukan Ç, Soyata AZ, Kurt A, et al. Long-term prophylactic transcranial direct current stimulation ameliorates allodynia and improves clinical outcomes in individuals with migraine. Neuromodulation. 2022. Long-term tDCS study.
23.
Zurück zum Zitat Rahimi MD, Fadardi JS, Saeidi M, Bigdeli I, Kashiri R. Effectiveness of cathodal tDCS of the primary motor or sensory cortex in migraine: a randomized controlled trial. Brain Stimul. 2020;13(3):675–82.PubMedCrossRef Rahimi MD, Fadardi JS, Saeidi M, Bigdeli I, Kashiri R. Effectiveness of cathodal tDCS of the primary motor or sensory cortex in migraine: a randomized controlled trial. Brain Stimul. 2020;13(3):675–82.PubMedCrossRef
24.
Zurück zum Zitat Mansour AG, Ahdab R, Khazen G, El-Khoury C, Sabbouh TM, Salem M, et al. Transcranial direct current stimulation of the occipital cortex in medication overuse headache: a pilot randomized controlled cross-over study. J Clin Med. 2020;9(4). Mansour AG, Ahdab R, Khazen G, El-Khoury C, Sabbouh TM, Salem M, et al. Transcranial direct current stimulation of the occipital cortex in medication overuse headache: a pilot randomized controlled cross-over study. J Clin Med. 2020;9(4).
25.
Zurück zum Zitat De Icco R, Putortì A, De Paoli I, Ferrara E, Cremascoli R, Terzaghi M, et al. Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: a pilot double-blind randomized sham-controlled trial. Clin Neurophysiol. 2021;132(1):126–36.PubMedCrossRef De Icco R, Putortì A, De Paoli I, Ferrara E, Cremascoli R, Terzaghi M, et al. Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: a pilot double-blind randomized sham-controlled trial. Clin Neurophysiol. 2021;132(1):126–36.PubMedCrossRef
26.
Zurück zum Zitat Hong P, Liu Y, Wan Y, Xiong H, Xu Y. Transcranial direct current stimulation for migraine: a systematic review and meta-analysis of randomized controlled trials. CNS Neurosci Ther. 2022;28(7):992–8.PubMedPubMedCentralCrossRef Hong P, Liu Y, Wan Y, Xiong H, Xu Y. Transcranial direct current stimulation for migraine: a systematic review and meta-analysis of randomized controlled trials. CNS Neurosci Ther. 2022;28(7):992–8.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat • de Brito Aranha REL, Torro-Alves N, Andrade SM, de Oliveira EA, Da Silva BNV, Da Fonseca É, et al. Effects on pain and cognition of transcranial direct current stimulation over the dorsolateral prefrontal cortex in women with chronic migraine. Neurophysiol Clin. 2022;52(4):333–8. tDCS over DLPFC in CM. • de Brito Aranha REL, Torro-Alves N, Andrade SM, de Oliveira EA, Da Silva BNV, Da Fonseca É, et al. Effects on pain and cognition of transcranial direct current stimulation over the dorsolateral prefrontal cortex in women with chronic migraine. Neurophysiol Clin. 2022;52(4):333–8. tDCS over DLPFC in CM.
28.
Zurück zum Zitat Dalla Volta G, Marceglia S, Zavarise P, Antonaci F. Cathodal tDCS guided by thermography as adjunctive therapy in chronic migraine patients: a sham-controlled pilot study. Front Neurol. 2020;11:121.PubMedPubMedCentralCrossRef Dalla Volta G, Marceglia S, Zavarise P, Antonaci F. Cathodal tDCS guided by thermography as adjunctive therapy in chronic migraine patients: a sham-controlled pilot study. Front Neurol. 2020;11:121.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Ornello R, Caponnetto V, Ratti S, D’Aurizio G, Rosignoli C, Pistoia F, et al. Which is the best transcranial direct current stimulation protocol for migraine prevention? A systematic review and critical appraisal of randomized controlled trials. J Headache Pain. 2021;22(1):144.PubMedPubMedCentralCrossRef Ornello R, Caponnetto V, Ratti S, D’Aurizio G, Rosignoli C, Pistoia F, et al. Which is the best transcranial direct current stimulation protocol for migraine prevention? A systematic review and critical appraisal of randomized controlled trials. J Headache Pain. 2021;22(1):144.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat • Grazzi L, Usai S, Bolognini N, Grignani E, Sansone E, Tramacere I, et al. No efficacy of transcranial direct current stimulation on chronic migraine with medication overuse: a double blind, randomised clinical trial. Cephalalgia. 2020;40(11):1202–11. A large multicenter study suggesting no efficacy of tDCS in CM. • Grazzi L, Usai S, Bolognini N, Grignani E, Sansone E, Tramacere I, et al. No efficacy of transcranial direct current stimulation on chronic migraine with medication overuse: a double blind, randomised clinical trial. Cephalalgia. 2020;40(11):1202–11. A large multicenter study suggesting no efficacy of tDCS in CM.
31.
Zurück zum Zitat Mastria G, Viganò A, Corrado A, Mancini V, Pirillo C, Badini S, et al. Chronic migraine preventive treatment by prefrontal-occipital transcranial direct current stimulation (tDCS): a proof-of-concept study on the effect of psychiatric comorbidities. Front Neurol. 2021;12:654900.PubMedPubMedCentralCrossRef Mastria G, Viganò A, Corrado A, Mancini V, Pirillo C, Badini S, et al. Chronic migraine preventive treatment by prefrontal-occipital transcranial direct current stimulation (tDCS): a proof-of-concept study on the effect of psychiatric comorbidities. Front Neurol. 2021;12:654900.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat •• Hodaj H, Payen JF, Mick G, Vercueil L, Hodaj E, Dumolard A, et al. Long-term prophylactic efficacy of transcranial direct current stimulation in chronic migraine. A randomised, patient-assessor blinded, sham-controlled trial. Brain stimulation. 2022;15(2):441–53. Long-term RCT on tDCS in CM. •• Hodaj H, Payen JF, Mick G, Vercueil L, Hodaj E, Dumolard A, et al. Long-term prophylactic efficacy of transcranial direct current stimulation in chronic migraine. A randomised, patient-assessor blinded, sham-controlled trial. Brain stimulation. 2022;15(2):441–53. Long-term RCT on tDCS in CM.
33.
Zurück zum Zitat •• Dawood Rahimi M, Taghi Kheirkhah M, Salehi FJ. Efficacy of tDCS in chronic migraine: a multiprotocol randomized controlled trial. Clin Neurophysiol. 2023;150:119–30. A new multiprotocol-design study of different parameters of tDCS in CM. •• Dawood Rahimi M, Taghi Kheirkhah M, Salehi FJ. Efficacy of tDCS in chronic migraine: a multiprotocol randomized controlled trial. Clin Neurophysiol. 2023;150:119–30. A new multiprotocol-design study of different parameters of tDCS in CM.
34.
Zurück zum Zitat Ornello R, Rosignoli C, Caponnetto V, Pistoia F, Ferrara M, D’Atri A, et al. Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): protocol for a randomized, double-blind, sham-controlled trial. Front Neurol. 2022;13: 890364.PubMedPubMedCentralCrossRef Ornello R, Rosignoli C, Caponnetto V, Pistoia F, Ferrara M, D’Atri A, et al. Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): protocol for a randomized, double-blind, sham-controlled trial. Front Neurol. 2022;13: 890364.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Lauritsen CG, Silberstein SD. Rationale for electrical parameter determination in external trigeminal nerve stimulation (eTNS) for migraine: a narrative review. Cephalalgia. 2019;39(6):750–60.PubMedCrossRef Lauritsen CG, Silberstein SD. Rationale for electrical parameter determination in external trigeminal nerve stimulation (eTNS) for migraine: a narrative review. Cephalalgia. 2019;39(6):750–60.PubMedCrossRef
36.
Zurück zum Zitat Schoenen JE. Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial. Neurology. 2016;86(2):201–2.PubMedCrossRef Schoenen JE. Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial. Neurology. 2016;86(2):201–2.PubMedCrossRef
37.
Zurück zum Zitat Magis D, Sava S, d’Elia TS, Baschi R, Schoenen J. Safety and patients’ satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly(R) device in headache treatment: a survey of 2,313 headache sufferers in the general population. J Headache Pain. 2013;14(1):95.PubMedPubMedCentralCrossRef Magis D, Sava S, d’Elia TS, Baschi R, Schoenen J. Safety and patients’ satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly(R) device in headache treatment: a survey of 2,313 headache sufferers in the general population. J Headache Pain. 2013;14(1):95.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Chou DE, Gross GJ, Casadei CH, Yugrakh MS. External trigeminal nerve stimulation for the acute treatment of migraine: open-label trial on safety and efficacy. Neuromodulation. 2017;20(7):678–83.PubMedCrossRef Chou DE, Gross GJ, Casadei CH, Yugrakh MS. External trigeminal nerve stimulation for the acute treatment of migraine: open-label trial on safety and efficacy. Neuromodulation. 2017;20(7):678–83.PubMedCrossRef
39.
Zurück zum Zitat Chou DE, Shnayderman Yugrakh M, Winegarner D, Rowe V, Kuruvilla D, Schoenen J. Acute migraine therapy with external trigeminal neurostimulation (ACME): a randomized controlled trial. Cephalalgia. 2019;39(1):3–14.PubMedCrossRef Chou DE, Shnayderman Yugrakh M, Winegarner D, Rowe V, Kuruvilla D, Schoenen J. Acute migraine therapy with external trigeminal neurostimulation (ACME): a randomized controlled trial. Cephalalgia. 2019;39(1):3–14.PubMedCrossRef
40.
Zurück zum Zitat Di Fiore P, Bussone G, Galli A, Didier H, Peccarisi C, D’Amico D, et al. Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial. Neurol Sci. 2017;38(Suppl 1):201–6.PubMedCrossRef Di Fiore P, Bussone G, Galli A, Didier H, Peccarisi C, D’Amico D, et al. Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial. Neurol Sci. 2017;38(Suppl 1):201–6.PubMedCrossRef
41.
Zurück zum Zitat Danno D, Iigaya M, Imai N, Igarashi H, Takeshima T. The safety and preventive effects of a supraorbital transcutaneous stimulator in Japanese migraine patients. Sci Rep. 2019;9(1):9900.PubMedPubMedCentralCrossRef Danno D, Iigaya M, Imai N, Igarashi H, Takeshima T. The safety and preventive effects of a supraorbital transcutaneous stimulator in Japanese migraine patients. Sci Rep. 2019;9(1):9900.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat • Trimboli M, Marsico O, Troisi L, Fasano F. External trigeminal neurostimulation in patients with chronic migraine. Pain Manag. 2023;13(3):185–92. Long follow-up study of Cefaly® in CM. • Trimboli M, Marsico O, Troisi L, Fasano F. External trigeminal neurostimulation in patients with chronic migraine. Pain Manag. 2023;13(3):185–92. Long follow-up study of Cefaly® in CM.
43.
Zurück zum Zitat Stanak M, Wolf S, Jagos H, Zebenholzer K. The impact of external trigeminal nerve stimulator (e-TNS) on prevention and acute treatment of episodic and chronic migraine: a systematic review. J Neurol Sci. 2020;412:116725.PubMedCrossRef Stanak M, Wolf S, Jagos H, Zebenholzer K. The impact of external trigeminal nerve stimulator (e-TNS) on prevention and acute treatment of episodic and chronic migraine: a systematic review. J Neurol Sci. 2020;412:116725.PubMedCrossRef
44.
Zurück zum Zitat Frangos E, Komisaruk BR. Access to vagal projections via cutaneous electrical stimulation of the neck: fMRI evidence in healthy humans. Brain Stimul. 2017;10(1):19–27.PubMedCrossRef Frangos E, Komisaruk BR. Access to vagal projections via cutaneous electrical stimulation of the neck: fMRI evidence in healthy humans. Brain Stimul. 2017;10(1):19–27.PubMedCrossRef
45.
Zurück zum Zitat Morais A, Liu TT, Qin T, Sadhegian H, Ay I, Yagmur D, et al. Vagus nerve stimulation inhibits cortical spreading depression exclusively through central mechanisms. Pain. 2020;161(7):1661–9.PubMedPubMedCentralCrossRef Morais A, Liu TT, Qin T, Sadhegian H, Ay I, Yagmur D, et al. Vagus nerve stimulation inhibits cortical spreading depression exclusively through central mechanisms. Pain. 2020;161(7):1661–9.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Cornelison LE, Hawkins JL, Woodman SE, Durham PL. Noninvasive vagus nerve stimulation and morphine transiently inhibit trigeminal pain signaling in a chronic headache model. Pain Rep. 2020;5(6):e881.PubMedPubMedCentralCrossRef Cornelison LE, Hawkins JL, Woodman SE, Durham PL. Noninvasive vagus nerve stimulation and morphine transiently inhibit trigeminal pain signaling in a chronic headache model. Pain Rep. 2020;5(6):e881.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Lerman I, Davis B, Huang M, Huang C, Sorkin L, Proudfoot J, et al. Noninvasive vagus nerve stimulation alters neural response and physiological autonomic tone to noxious thermal challenge. PLoS ONE. 2019;14(2):e0201212.PubMedPubMedCentralCrossRef Lerman I, Davis B, Huang M, Huang C, Sorkin L, Proudfoot J, et al. Noninvasive vagus nerve stimulation alters neural response and physiological autonomic tone to noxious thermal challenge. PLoS ONE. 2019;14(2):e0201212.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Schroeder CF, Moller M, May A. nVNS sham significantly affects the trigeminal-autonomic reflex: a randomized controlled study. Neurology. 2019;93(5):e518–21.PubMedCrossRef Schroeder CF, Moller M, May A. nVNS sham significantly affects the trigeminal-autonomic reflex: a randomized controlled study. Neurology. 2019;93(5):e518–21.PubMedCrossRef
49.
Zurück zum Zitat Moller M, Mehnert J, Schroeder CF, May A. Noninvasive vagus nerve stimulation and the trigeminal autonomic reflex: an fMRI study. Neurology. 2020;94(10):e1085–93.PubMedCrossRef Moller M, Mehnert J, Schroeder CF, May A. Noninvasive vagus nerve stimulation and the trigeminal autonomic reflex: an fMRI study. Neurology. 2020;94(10):e1085–93.PubMedCrossRef
50.
Zurück zum Zitat Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018;91(4):e364–73.PubMedPubMedCentralCrossRef Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018;91(4):e364–73.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Silberstein SD, Calhoun AH, Lipton RB, Grosberg BM, Cady RK, Dorlas S, et al. Chronic migraine headache prevention with noninvasive vagus nerve stimulation: the EVENT study. Neurology. 2016;87(5):529–38.PubMedPubMedCentralCrossRef Silberstein SD, Calhoun AH, Lipton RB, Grosberg BM, Cady RK, Dorlas S, et al. Chronic migraine headache prevention with noninvasive vagus nerve stimulation: the EVENT study. Neurology. 2016;87(5):529–38.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Kinfe TM, Pintea B, Muhammad S, Zaremba S, Roeske S, Simon BJ, et al. Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: a prospective observational cohort study. J Headache Pain. 2015;16:101.PubMedPubMedCentralCrossRef Kinfe TM, Pintea B, Muhammad S, Zaremba S, Roeske S, Simon BJ, et al. Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: a prospective observational cohort study. J Headache Pain. 2015;16:101.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Lai YH, Huang YC, Huang LT, Chen RM, Chen C. Cervical noninvasive vagus nerve stimulation for migraine and cluster headache: a systematic review and meta-analysis. Neuromodulation. 2020;23(6):721–31.PubMedCrossRef Lai YH, Huang YC, Huang LT, Chen RM, Chen C. Cervical noninvasive vagus nerve stimulation for migraine and cluster headache: a systematic review and meta-analysis. Neuromodulation. 2020;23(6):721–31.PubMedCrossRef
54.
Zurück zum Zitat Trimboli M, Al-Kaisy A, Andreou AP, Murphy M, Lambru G. Non-invasive vagus nerve stimulation for the management of refractory primary chronic headaches: a real-world experience. Cephalalgia. 2018;38(7):1276–85.PubMedCrossRef Trimboli M, Al-Kaisy A, Andreou AP, Murphy M, Lambru G. Non-invasive vagus nerve stimulation for the management of refractory primary chronic headaches: a real-world experience. Cephalalgia. 2018;38(7):1276–85.PubMedCrossRef
55.
Zurück zum Zitat • Sacca V, Zhang Y, Cao J, Li H, Yan Z, Ye Y, et al. Evaluation of the modulation effects evoked by different transcutaneous auricular vagus nerve stimulation frequencies along the central vagus nerve pathway in migraine: a functional magnetic resonance imaging study. Neuromodulation. 2023;26(3):620–8. A fMRI study of VNS with different frequencies for migraine. • Sacca V, Zhang Y, Cao J, Li H, Yan Z, Ye Y, et al. Evaluation of the modulation effects evoked by different transcutaneous auricular vagus nerve stimulation frequencies along the central vagus nerve pathway in migraine: a functional magnetic resonance imaging study. Neuromodulation. 2023;26(3):620–8. A fMRI study of VNS with different frequencies for migraine.
56.
Zurück zum Zitat Babaei M, Rapoport AM. Device profile of Nerivio for the acute and preventive treatment of episodic or chronic migraine in patients 12 years and older. Expert Rev Med Devices. 2023;20(6):433–47.PubMedCrossRef Babaei M, Rapoport AM. Device profile of Nerivio for the acute and preventive treatment of episodic or chronic migraine in patients 12 years and older. Expert Rev Med Devices. 2023;20(6):433–47.PubMedCrossRef
57.
Zurück zum Zitat Ailani J, Rabany L, Tamir S, Ironi A, Starling A. Real-world analysis of remote electrical neuromodulation (REN) for the acute treatment of migraine. Front Pain Res (Lausanne). 2021;2: 753736.PubMedCrossRef Ailani J, Rabany L, Tamir S, Ironi A, Starling A. Real-world analysis of remote electrical neuromodulation (REN) for the acute treatment of migraine. Front Pain Res (Lausanne). 2021;2: 753736.PubMedCrossRef
58.
Zurück zum Zitat Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ironi A, Harris D, et al. Remote electrical neuromodulation (REN) relieves acute migraine: a randomized, double-blind, placebo-controlled, multicenter trial. Headache. 2019;59(8):1240–52.PubMedPubMedCentralCrossRef Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ironi A, Harris D, et al. Remote electrical neuromodulation (REN) relieves acute migraine: a randomized, double-blind, placebo-controlled, multicenter trial. Headache. 2019;59(8):1240–52.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Rapoport AM, Lin T, Tepper SJ. Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine. Headache. 2020;60(1):229–34.PubMedCrossRef Rapoport AM, Lin T, Tepper SJ. Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine. Headache. 2020;60(1):229–34.PubMedCrossRef
60.
Zurück zum Zitat Rapoport AM, Bonner JH, Lin T, Harris D, Gruper Y, Ironi A, et al. Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications. J Headache Pain. 2019;20(1):83.PubMedPubMedCentralCrossRef Rapoport AM, Bonner JH, Lin T, Harris D, Gruper Y, Ironi A, et al. Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications. J Headache Pain. 2019;20(1):83.PubMedPubMedCentralCrossRef
61.
Zurück zum Zitat Marmura MJ, Lin T, Harris D, Ironi A, Rosen NL. Incorporating remote electrical neuromodulation (REN) into usual care reduces acute migraine medication use: an open-label extension study. Front Neurol. 2020;11:226.PubMedPubMedCentralCrossRef Marmura MJ, Lin T, Harris D, Ironi A, Rosen NL. Incorporating remote electrical neuromodulation (REN) into usual care reduces acute migraine medication use: an open-label extension study. Front Neurol. 2020;11:226.PubMedPubMedCentralCrossRef
62.
Zurück zum Zitat Tepper SJ, Rabany L, Cowan RP, Smith TR, Grosberg BM, Torphy BD, et al. Remote electrical neuromodulation for migraine prevention: a double-blind, randomized, placebo-controlled clinical trial. Headache. 2023;63(3):377–89.PubMedCrossRef Tepper SJ, Rabany L, Cowan RP, Smith TR, Grosberg BM, Torphy BD, et al. Remote electrical neuromodulation for migraine prevention: a double-blind, randomized, placebo-controlled clinical trial. Headache. 2023;63(3):377–89.PubMedCrossRef
63.
Zurück zum Zitat Cowan R, Stark-Inbar A, Rabany L, Harris D, Vizel M, Ironi A, et al. Clinical benefits and economic cost-savings of remote electrical neuromodulation (REN) for migraine prevention. J Med Econ. 2023;26(1):656–64.PubMedCrossRef Cowan R, Stark-Inbar A, Rabany L, Harris D, Vizel M, Ironi A, et al. Clinical benefits and economic cost-savings of remote electrical neuromodulation (REN) for migraine prevention. J Med Econ. 2023;26(1):656–64.PubMedCrossRef
64.
Zurück zum Zitat Nierenburg H, Vieira JR, Lev N, Lin T, Harris D, Vizel M, et al. Remote electrical neuromodulation for the acute treatment of migraine in patients with chronic migraine: an open-label pilot study. Pain Ther. 2020;9(2):531–43.PubMedPubMedCentralCrossRef Nierenburg H, Vieira JR, Lev N, Lin T, Harris D, Vizel M, et al. Remote electrical neuromodulation for the acute treatment of migraine in patients with chronic migraine: an open-label pilot study. Pain Ther. 2020;9(2):531–43.PubMedPubMedCentralCrossRef
65.
Zurück zum Zitat • Grosberg B, Rabany L, Lin T, Harris D, Vizel M, Ironi A, et al. Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study. Pain Rep. 2021;6(4): e966. REN in acute treatment of CM. • Grosberg B, Rabany L, Lin T, Harris D, Vizel M, Ironi A, et al. Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study. Pain Rep. 2021;6(4): e966. REN in acute treatment of CM.
66.
Zurück zum Zitat • Grosberg B, Rabany L, Vizel M, Ironi A, Harris D, Stark-Inbar A, et al. Effectiveness comparison of remote electrical neuromodulation and standard-care medications for acute treatment of chronic migraine: a post-hoc analysis. Pain Manag. 2022;12(7):837–44. Comparative research of REN and standard-care medications. • Grosberg B, Rabany L, Vizel M, Ironi A, Harris D, Stark-Inbar A, et al. Effectiveness comparison of remote electrical neuromodulation and standard-care medications for acute treatment of chronic migraine: a post-hoc analysis. Pain Manag. 2022;12(7):837–44. Comparative research of REN and standard-care medications.
67.
Zurück zum Zitat Liu Y, Dong Z, Wang R, Ao R, Han X, Tang W, et al. Migraine prevention using different frequencies of transcutaneous occipital nerve stimulation: a randomized controlled trial. J Pain. 2017;18(8):1006–15.PubMedCrossRef Liu Y, Dong Z, Wang R, Ao R, Han X, Tang W, et al. Migraine prevention using different frequencies of transcutaneous occipital nerve stimulation: a randomized controlled trial. J Pain. 2017;18(8):1006–15.PubMedCrossRef
68.
Zurück zum Zitat Daniel O, Sharon R, Tepper SJ. A device review of Relivion(R): an external combined occipital and trigeminal neurostimulation (eCOT-NS) system for self-administered treatment of migraine and major depressive disorder. Expert Rev Med Devices. 2021;18(4):333–42.PubMedCrossRef Daniel O, Sharon R, Tepper SJ. A device review of Relivion(R): an external combined occipital and trigeminal neurostimulation (eCOT-NS) system for self-administered treatment of migraine and major depressive disorder. Expert Rev Med Devices. 2021;18(4):333–42.PubMedCrossRef
69.
Zurück zum Zitat • Daniel O, Tepper SJ, Deutsch L, Sharon R. External concurrent occipital and trigeminal neurostimulation relieves migraine headache: a prospective, randomized, double-blind, sham-controlled trial. Pain Ther. 2022;11(3):907–22. A new eCOT-NS system for migraine. • Daniel O, Tepper SJ, Deutsch L, Sharon R. External concurrent occipital and trigeminal neurostimulation relieves migraine headache: a prospective, randomized, double-blind, sham-controlled trial. Pain Ther. 2022;11(3):907–22. A new eCOT-NS system for migraine
70.
Zurück zum Zitat Deng Y, Zheng M, He L, Yang J, Yu G, Wang J. A head-to-head comparison of percutaneous mastoid electrical stimulator and supraorbital transcutaneous stimulator in the prevention of migraine: a prospective, randomized controlled study. Neuromodulation. 2020;23(6):770–7.PubMedCrossRef Deng Y, Zheng M, He L, Yang J, Yu G, Wang J. A head-to-head comparison of percutaneous mastoid electrical stimulator and supraorbital transcutaneous stimulator in the prevention of migraine: a prospective, randomized controlled study. Neuromodulation. 2020;23(6):770–7.PubMedCrossRef
71.
Zurück zum Zitat Börner C, Renner T, Trepte-Freisleder F, Urban G, Schandelmaier P, Lang M, et al. Response predictors of repetitive neuromuscular magnetic stimulation in the preventive treatment of episodic migraine. Front Neurol. 2022;13: 919623.PubMedPubMedCentralCrossRef Börner C, Renner T, Trepte-Freisleder F, Urban G, Schandelmaier P, Lang M, et al. Response predictors of repetitive neuromuscular magnetic stimulation in the preventive treatment of episodic migraine. Front Neurol. 2022;13: 919623.PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Wilkinson D, Ade KK, Rogers LL, Attix DK, Kuchibhatla M, Slade MD, et al. Preventing episodic migraine with caloric vestibular stimulation: a randomized controlled trial. Headache. 2017;57(7):1065–87.PubMedCrossRef Wilkinson D, Ade KK, Rogers LL, Attix DK, Kuchibhatla M, Slade MD, et al. Preventing episodic migraine with caloric vestibular stimulation: a randomized controlled trial. Headache. 2017;57(7):1065–87.PubMedCrossRef
73.
Zurück zum Zitat Juan Y, Shu O, Jinhe L, Na Y, Yushuang D, Weiwei D, et al. Migraine prevention with percutaneous mastoid electrical stimulator: a randomized double-blind controlled trial. Cephalalgia. 2017;37(13):1248–56.PubMedCrossRef Juan Y, Shu O, Jinhe L, Na Y, Yushuang D, Weiwei D, et al. Migraine prevention with percutaneous mastoid electrical stimulator: a randomized double-blind controlled trial. Cephalalgia. 2017;37(13):1248–56.PubMedCrossRef
74.
Zurück zum Zitat • Al-Kaisy A, Palmisani S, Carganillo R, Wesley S, Pang D, Rotte A, et al. Safety and efficacy of 10 kHz spinal cord stimulation for the treatment of refractory chronic migraine: a prospective long-term open-label study. Neuromodulation. 2022;25(1):103–13. Spinal cord stimulation in CM. • Al-Kaisy A, Palmisani S, Carganillo R, Wesley S, Pang D, Rotte A, et al. Safety and efficacy of 10 kHz spinal cord stimulation for the treatment of refractory chronic migraine: a prospective long-term open-label study. Neuromodulation. 2022;25(1):103–13. Spinal cord stimulation in CM.
75.
Zurück zum Zitat Govind N. Acupuncture for the prevention of episodic migraine. Res Nurs Health. 2019;42(1):87–8.PubMedCrossRef Govind N. Acupuncture for the prevention of episodic migraine. Res Nurs Health. 2019;42(1):87–8.PubMedCrossRef
76.
Zurück zum Zitat Xu S, Yu L, Luo X, Wang M, Chen G, Zhang Q, et al. Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial. BMJ. 2020;368:m697.PubMedPubMedCentralCrossRef Xu S, Yu L, Luo X, Wang M, Chen G, Zhang Q, et al. Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial. BMJ. 2020;368:m697.PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Liao CC, Liao KR, Lin CL, Li JM. Long-term effect of acupuncture on the medical expenditure and risk of depression and anxiety in migraine patients: a retrospective cohort study. Front Neurol. 2020;11:321.PubMedPubMedCentralCrossRef Liao CC, Liao KR, Lin CL, Li JM. Long-term effect of acupuncture on the medical expenditure and risk of depression and anxiety in migraine patients: a retrospective cohort study. Front Neurol. 2020;11:321.PubMedPubMedCentralCrossRef
78.
Zurück zum Zitat Hu T, Hu H, Chen F, Jiang B, Shen F, Su Y, et al. The efficacy and safety of acupuncture for prophylaxis of vestibular migraine: a study protocol for a randomized controlled trial. Front Neurol. 2021;12:709803.PubMedPubMedCentralCrossRef Hu T, Hu H, Chen F, Jiang B, Shen F, Su Y, et al. The efficacy and safety of acupuncture for prophylaxis of vestibular migraine: a study protocol for a randomized controlled trial. Front Neurol. 2021;12:709803.PubMedPubMedCentralCrossRef
79.
Zurück zum Zitat Fan SQ, Jin S, Tang TC, Chen M, Zheng H. Efficacy of acupuncture for migraine prophylaxis: a trial sequential meta-analysis. J Neurol. 2021;268(11):4128–37.PubMedCrossRef Fan SQ, Jin S, Tang TC, Chen M, Zheng H. Efficacy of acupuncture for migraine prophylaxis: a trial sequential meta-analysis. J Neurol. 2021;268(11):4128–37.PubMedCrossRef
80.
Zurück zum Zitat Liu L, Zhao LP, Zhang CS, Zeng L, Wang K, Zhao J, et al. Acupuncture as prophylaxis for chronic migraine: a protocol for a single-blinded, double-dummy randomised controlled trial. BMJ Open. 2018;8(5):e020653.PubMedPubMedCentralCrossRef Liu L, Zhao LP, Zhang CS, Zeng L, Wang K, Zhao J, et al. Acupuncture as prophylaxis for chronic migraine: a protocol for a single-blinded, double-dummy randomised controlled trial. BMJ Open. 2018;8(5):e020653.PubMedPubMedCentralCrossRef
81.
Zurück zum Zitat Zou Y, Tang W, Li X, Xu M, Li J. Acupuncture reversible effects on altered default mode network of chronic migraine accompanied with clinical symptom relief. Neural Plast. 2019;2019:5047463.PubMedPubMedCentralCrossRef Zou Y, Tang W, Li X, Xu M, Li J. Acupuncture reversible effects on altered default mode network of chronic migraine accompanied with clinical symptom relief. Neural Plast. 2019;2019:5047463.PubMedPubMedCentralCrossRef
82.
Zurück zum Zitat Naderinabi B, Saberi A, Hashemi M, Haghighi M, Biazar G, Abolhasan Gharehdaghi F, et al. Acupuncture and botulinum toxin A injection in the treatment of chronic migraine: a randomized controlled study. Caspian J Intern Med. 2017;8(3):196–204.PubMedPubMedCentral Naderinabi B, Saberi A, Hashemi M, Haghighi M, Biazar G, Abolhasan Gharehdaghi F, et al. Acupuncture and botulinum toxin A injection in the treatment of chronic migraine: a randomized controlled study. Caspian J Intern Med. 2017;8(3):196–204.PubMedPubMedCentral
83.
Zurück zum Zitat • Zheng H, Huang S, Chen Y, Tang T, Qin D, Chen M. Topiramate, acupuncture, and BoNT-A for chronic migraine: a network meta-analysis. Acta Neurol Scand. 2021;143(5):558–68. Combination of CBT and amitriptyline in CM. • Zheng H, Huang S, Chen Y, Tang T, Qin D, Chen M. Topiramate, acupuncture, and BoNT-A for chronic migraine: a network meta-analysis. Acta Neurol Scand. 2021;143(5):558–68. Combination of CBT and amitriptyline in CM.
84.
Zurück zum Zitat Allais G, Sinigaglia S, Airola G, Rolando S, De Lorenzo C, Chiarle G, et al. Ear acupuncture in the prophylactic treatment of chronic migraine. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2019;40:211–2.PubMedCrossRef Allais G, Sinigaglia S, Airola G, Rolando S, De Lorenzo C, Chiarle G, et al. Ear acupuncture in the prophylactic treatment of chronic migraine. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2019;40:211–2.PubMedCrossRef
85.
Zurück zum Zitat Onur OS, Ertem DH, Karsidag C, Uluduz D, Ozge A, Siva A, et al. An open/pilot trial of cognitive behavioral therapy in Turkish patients with refractory chronic migraine. Cogn Neurodyn. 2019;13(2):183–9.PubMedPubMedCentralCrossRef Onur OS, Ertem DH, Karsidag C, Uluduz D, Ozge A, Siva A, et al. An open/pilot trial of cognitive behavioral therapy in Turkish patients with refractory chronic migraine. Cogn Neurodyn. 2019;13(2):183–9.PubMedPubMedCentralCrossRef
86.
Zurück zum Zitat •• Dudeney J, Sharpe L, McDonald S, Menzies RE, McGuire B. Are psychological interventions efficacious for adults with migraine? A systematic review and meta-analysis Headache. 2022;62(4):405–19. A systematic review of psychological interventions in migraine. •• Dudeney J, Sharpe L, McDonald S, Menzies RE, McGuire B. Are psychological interventions efficacious for adults with migraine? A systematic review and meta-analysis Headache. 2022;62(4):405–19. A systematic review of psychological interventions in migraine.
87.
Zurück zum Zitat Bae JY, Sung HK, Kwon NY, Go HY, Kim TJ, Shin SM, et al. Cognitive behavioral therapy for migraine headache: a systematic review and meta-analysis. Medicina (Kaunas). 2021;58(1). Bae JY, Sung HK, Kwon NY, Go HY, Kim TJ, Shin SM, et al. Cognitive behavioral therapy for migraine headache: a systematic review and meta-analysis. Medicina (Kaunas). 2021;58(1).
88.
Zurück zum Zitat Langenbahn D, Matsuzawa Y, Lee Y, Fraser F, Penzien D, Simon N, et al. Underuse of behavioral treatments for headache: a narrative review examining societal and cultural factors. J Gen Intern Med. 2021;36(10):3103–12.PubMedPubMedCentralCrossRef Langenbahn D, Matsuzawa Y, Lee Y, Fraser F, Penzien D, Simon N, et al. Underuse of behavioral treatments for headache: a narrative review examining societal and cultural factors. J Gen Intern Med. 2021;36(10):3103–12.PubMedPubMedCentralCrossRef
89.
Zurück zum Zitat Grazzi L, Montisano DA, Raggi A, Rizzoli P. The be-home kids program: an integrated approach for delivering behavioral therapies to adolescents with episodic and chronic migraine. Brain Sci. 2023;13(4). Grazzi L, Montisano DA, Raggi A, Rizzoli P. The be-home kids program: an integrated approach for delivering behavioral therapies to adolescents with episodic and chronic migraine. Brain Sci. 2023;13(4).
90.
Zurück zum Zitat • Rettig EK, Ergun G, Warfield JR, Slater SK, LeCates SL, Kabbouche MA, et al. Predictors of improvement in pediatric chronic migraine: results from the cognitive-behavioral therapy and amitriptyline trial. J Clin Psychol Med Settings. 2022;29(1):113–9. Combination of CBT and amitriptyline in CM. • Rettig EK, Ergun G, Warfield JR, Slater SK, LeCates SL, Kabbouche MA, et al. Predictors of improvement in pediatric chronic migraine: results from the cognitive-behavioral therapy and amitriptyline trial. J Clin Psychol Med Settings. 2022;29(1):113–9. Combination of CBT and amitriptyline in CM.
91.
Zurück zum Zitat Kroon Van Diest AM, Ramsey RR, Kashikar-Zuck S, Slater S, Hommel K, Kroner JW, et al. Treatment adherence in child and adolescent chronic migraine patients: results from the cognitive-behavioral therapy and amitriptyline trial. Clin J Pain. 2017;33(10):892–8. Kroon Van Diest AM, Ramsey RR, Kashikar-Zuck S, Slater S, Hommel K, Kroner JW, et al. Treatment adherence in child and adolescent chronic migraine patients: results from the cognitive-behavioral therapy and amitriptyline trial. Clin J Pain. 2017;33(10):892–8.
92.
Zurück zum Zitat Pimenta LDS, de Araújo ELM, Silva J, França JJ, Brito PNA, de Holanda LJ, et al. Effects of synergism of mindfulness practice associated with transcranial direct-current stimulation in chronic migraine: pilot, randomized, controlled, double-blind clinical trial. Front Hum Neurosci. 2021;15:769619.PubMedPubMedCentralCrossRef Pimenta LDS, de Araújo ELM, Silva J, França JJ, Brito PNA, de Holanda LJ, et al. Effects of synergism of mindfulness practice associated with transcranial direct-current stimulation in chronic migraine: pilot, randomized, controlled, double-blind clinical trial. Front Hum Neurosci. 2021;15:769619.PubMedPubMedCentralCrossRef
93.
Zurück zum Zitat Buse DC, Rabany L, Lin T, Ironi A, Connelly MA, Bickel JL. Combining guided intervention of education and relaxation (GIER) with remote electrical neuromodulation (REN) in the acute treatment of migraine. Pain Med. 2022;23(9):1544–9.PubMedCrossRef Buse DC, Rabany L, Lin T, Ironi A, Connelly MA, Bickel JL. Combining guided intervention of education and relaxation (GIER) with remote electrical neuromodulation (REN) in the acute treatment of migraine. Pain Med. 2022;23(9):1544–9.PubMedCrossRef
94.
Zurück zum Zitat • Grazzi L, Telesca A, Rizzoli P. Management of chronic migraine with medication overuse by web-based behavioral program during the COVID-19 emergency: results at 12 months. Neurol Sci. 2022;43(3):1583–5. A web-based psychological intervention for CM during COVID-19. • Grazzi L, Telesca A, Rizzoli P. Management of chronic migraine with medication overuse by web-based behavioral program during the COVID-19 emergency: results at 12 months. Neurol Sci. 2022;43(3):1583–5. A web-based psychological intervention for CM during COVID-19.
95.
Zurück zum Zitat Meise R, Carvalho GF, Thiel C, Luedtke K. Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine: a randomized controlled trial. Cephalalgia. 2023;43(2):3331024221144781.PubMedCrossRef Meise R, Carvalho GF, Thiel C, Luedtke K. Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine: a randomized controlled trial. Cephalalgia. 2023;43(2):3331024221144781.PubMedCrossRef
96.
Zurück zum Zitat Bevilaqua-Grossi D, Pinheiro-Araujo CF, Carvalho GF, Florencio LL. Neck pain repercussions in migraine - the role of physiotherapy. Musculoskelet Sci Pract. 2023:102786. Bevilaqua-Grossi D, Pinheiro-Araujo CF, Carvalho GF, Florencio LL. Neck pain repercussions in migraine - the role of physiotherapy. Musculoskelet Sci Pract. 2023:102786.
97.
Zurück zum Zitat Kurt A, Turhan B. Physiotherapy management of migraine pain: facial proprioceptive neuromuscular facilitation technique versus connective tissue massage. J Craniofac Surg. 2022;33(8):2328–32.PubMedCrossRef Kurt A, Turhan B. Physiotherapy management of migraine pain: facial proprioceptive neuromuscular facilitation technique versus connective tissue massage. J Craniofac Surg. 2022;33(8):2328–32.PubMedCrossRef
98.
Zurück zum Zitat Deodato M, Granato A, Borgino C, Galmonte A, Manganotti P. Instrumental assessment of physiotherapy and onabotulinumtoxin-A on cervical and headache parameters in chronic migraine. Neurol Sci. 2022;43(3):2021–9.PubMedCrossRef Deodato M, Granato A, Borgino C, Galmonte A, Manganotti P. Instrumental assessment of physiotherapy and onabotulinumtoxin-A on cervical and headache parameters in chronic migraine. Neurol Sci. 2022;43(3):2021–9.PubMedCrossRef
99.
Zurück zum Zitat Lendraitiene E, Smilgiene L, Petruseviciene D, Savickas R. Changes and associations between cervical range of motion, pain, temporomandibular joint range of motion and quality of life in individuals with migraine applying physiotherapy: a pilot study. Medicina (Kaunas). 2021;57(6). Lendraitiene E, Smilgiene L, Petruseviciene D, Savickas R. Changes and associations between cervical range of motion, pain, temporomandibular joint range of motion and quality of life in individuals with migraine applying physiotherapy: a pilot study. Medicina (Kaunas). 2021;57(6).
Metadaten
Titel
Non-Pharmacological Treatment for Chronic Migraine
verfasst von
Xun Han
Shengyuan Yu
Publikationsdatum
23.08.2023
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 11/2023
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-023-01162-x

Weitere Artikel der Ausgabe 11/2023

Current Pain and Headache Reports 11/2023 Zur Ausgabe

Regenerative Pain Medicine/Interventional Pain Medicine (E Cornett Bradley, Section Editor)

Analgesic Techniques for Rib Fractures—A Comprehensive Review Article

Acute Pain Medicine (R Urman, Section Editor)

Simulation-Based Education in Acute and Chronic Pain Training

Anesthetic Techniques in Pain Management (D Wang, Section Editor)

SPECT/CT Scan: A New Diagnostic Tool in Pain Medicine

Hot Topics in Pain and Headache (N Rosen, Section Editor)

Does Tension Headache Have a Central or Peripheral Origin? Current State of Affairs

Anesthetic Techniques in Pain Management (D Wang, Section Editor)

Current Neurostimulation Therapies for Chronic Pain Conditions

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Schlaganfall: Frühzeitige Blutdrucksenkung im Krankenwagen ohne Nutzen

31.05.2024 Apoplex Nachrichten

Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.

Reanimation bei Kindern – besser vor Ort oder während Transport?

29.05.2024 Reanimation im Kindesalter Nachrichten

Zwar scheint es laut einer Studie aus den USA und Kanada bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.